Progesterone protective effects in neurodegeneration and neuroinflammation

Journal of Neuroendocrinology

Volumn 25, Issue 11, 2013, Pages 1095-1103

  De Nicola, A F ^a   Gonzalez Deniselle, M C ^a   Garay, L ^a   Meyer, M ^a   Gargiulo Monachelli, G ^a   Guennoun, R ^b   Schumacher, M ^b   Carreras, M C ^c   Poderoso, J J ^c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anti inflammatory effects; Experimental autoimmune encephalomyelitis; Neuroprotection; Progesterone; Wobbler mouse

Indexed keywords

CD11B ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE TYPE 2; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROGESTERONE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; GESTAGEN; NEUROPROTECTIVE AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BICEPS BRACHII MUSCLE; ENZYME ACTIVITY; GLIA CELL; HUMAN; LONG TERM CARE; MICROGLIA; MOTONEURON; MOTOR DYSFUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; ANIMAL; DISEASE MODEL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MOUSE; NEURODEGENERATIVE DISEASES;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PROGESTERONE; PROGESTINS;

EID: 84886669862     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12043     Document Type: Review

References (75)

1. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007; 116: 77-106.
2. De Nicola AF, Labombarda F, Deniselle MC, Gonzalez SL, Garay L, Meyer M, Gargiulo G, Guennoun R, Schumacher M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol 2009; 30: 173-187.
3. Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 2008; 57: 386-397.
4. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ, Nilsen J. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008; 29: 313-339.
5. Leonelli E, Bianchi G, Cavaletti D, Caruso D, Crippa D, García-Segura LM, Lauria G, Roglio L, Melcangi RC. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007; 144: 1293-1304.
6. Mensah-Nyagan AG, Meyer L, Schaeffer V, Kibalyand C, Patte-Mensah C. Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology 2009; 34: 169-177.
7. Coronel MF, Labombarda F, Roig P, Villar MJ, De Nicola AF, González SL. Progesterone prevents nerve injury-induced allodynia and spinal NMDA receptor upregulation in rats. Pain Med 2011; 12: 1249-1261.
8. Liu A, Margaill I, Zhang S, Labombarda F, Coqueran B, Delespierre B, Liere P, Marchand-Leroux C, O'Malley BW, Lydon JP, De Nicola AF, Sitruk-Ware R, Mattern C, Plotkine M, Schumacher M, Guennoun R. Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 2012; 153: 3747-3757.
9. Cudkowicz ME, Brown RH. Amyotrophic lateral sclerosis and related motor neuron diseases. In: Jameson JL, ed. Principles of Molecular Medicine. Clifton, NJ: Humana Press, 1998: 907-911.
10. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585.
11. Mitsumoto H, Bradley WG. Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain 1982; 105: 811-834.
12. Boillee S, Peschanski M, Junier MP. The wobbler mouse: a neurodegeneration jigsaw puzzle. Mol Neurobiol 2003; 28: 65-106.
13. Dennis JS, Citron BA. Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein. Neuroscience 2009; 158: 745-750.
14. Hantaz-Ambroise D, Jacque C, Ait IA, Parmentier C, Leclerc P, Cambier D, Zadigue G, Rieger F. Specific features of chronic astrocyte gliosis after experimental central nervous system (CNS) xenografting and in Wobbler neurological mutant CNS. Differentiation 2001; 69: 100-107.
15. Diana V, Ottolina A, Botti F, Fumagalli E, Calcagno E, De Paola M, Cagnotto A, Invernici G, Parati E, Curti D, Mennini T. Neural precursor-derived astrocytes of wobbler mice induce apoptotic death of motor neurons through reduced glutamate uptake. Exp Neurol 2010; 225: 163-172.
16. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990; 181: 195-213.
17. Tsuzaka KT, Ishiyama EP, Pioro P, Mitsumoto H. Role of brain-derived neurotrophic factor in Wobbler mouse motor neuron disease. Muscle Nerve 2001; 24: 474-480.
18. Henderson JT, Javaheri M, Kopko S, Roder JC. Reduction of lower motor neuron degeneration in wobbler mice by n-acetyl-l-cysteine. J Neurosci 1996; 16: 7574-7582.
19. Gonzalez Deniselle MC, López-Costa JJ, Saavedra JP, Pietranera L, Gonzalez SL, Garay L, Guennoun R, Schumacher M, De Nicola AF. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 2002; 11: 457-468.
20. Clowry GJ, McHanwell S. Expression of nitric oxide synthase by motor neurons in the spinal cord of the mutant mouse wobble. Neurosci Lett 1996; 215: 177-180.
21. Gonzalez Deniselle MC, Garay L, Gonzalez S, Guennoun R, Schumacher M, De Nicola AF. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease. Exp Neurol 2005; 195: 518-523.
22. Carreras MC, Franco MC, Peralta JG, Poderoso JJ. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol Aspects Med 2004; 25: 125-139.
23. Majewska MD, Harrison NL, Shwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1981; 232: 1004-1007.
24. Zhu Y, Hanna RN, Schaaf MJ, Spaink HP, Thomas P. Candidates for membrane progestin receptors - past approaches and future challenges. Comp Biochem Physiol C Toxicol Pharmacol 2008; 148: 381-389.
25. Guennoun R, Meffre D, Labombarda F, Gonzalez SL, Deniselle MC, Stein DG, De Nicola AF, Schumacher M. The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res Rev 2008; 57: 493-505.
26. A receptor complex, attenuate pain sensitivity in rats. Brain Res 1994; 643: 194-203.
27. Gonzalez Deniselle MC, Garay L, Gonzalez S, Saravia F, Labombarda F, Guennoun R, Schumacher M, De Nicola AF. Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Exp Neurol 2007; 203: 406-414.
28. Ishiyama T, Ogo H, Wong V, Klinkosz B, Noguchi H, Nakayama C, Mitsumoto H. Methionine-free brain derived neurotrophic factor in wobbler mouse motor neuron disease: dose-related effects and comparison with the methionyl form. Brain Res 2002; 944: 195-199.
29. Meyer M, Gonzalez Deniselle MC, Gargiulo-Monachelli G, Garay LI, Schumacher M, Guennoun R, De Nicola AF. Progesterone effects on neuronal brain-derived neurotrophic factor and glial cells during progression of Wobbler mouse neurodegeneration. Neuroscience 2012; 201: 267-279.
30. Nagappan G, Lu B. Activity-dependent modulation of BDNF receptor TrkB: mechanisms and implications. Trends Neurosci 2005; 28: 464-471.
31. Meyer M, Gonzalez Deniselle MC, Garay LI, Monachelli GG, Lima A, Roig P, Guennoun R, Schumacher M, De Nicola AF. Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration. Cell Mol Neurobiol 2010; 30: 123-135.
32. Beck T, Lindholm D, Castrén E, Wree A. BDNF protects against ischemia cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994; 14: 689-692.
33. Chun HS, Son JJ, Son JH. Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implications in Parkinson′s disease. NeuroReport 2000; 11: 511-514.
34. Koda M, Murakami M, Ino H, Yoshinaga K, Ikeda O, Hashimoto M, Yamazaki M, Nakayama C, Moriya H. Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats. J Neurotrauma 2002; 19: 777-785.
35. Oda Y, Imai S, Nakanishi I, Ichikawa T, Deguchi T. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol Int 1995; 45: 933-939.
36. Blondet B, Barlovatz-Meimon G, Festoff BW, Soria C, Soria J, Rieger F, Hantai D. Plasminogen activator in the neuromuscular system of the wobbler mutant mouse. Brain Res 1992; 580: 303-310.
37. González Deniselle MC, Garay L, López-Costa JJ, González S, Mougel A, Guennoun R, Schumacher M, De Nicola AF. Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease. Brain Res, 2004; 1014: 71-79.
38. Dave KR, Bradley WG, Pérez-Pinzón MA. Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse. Exp Neurol 2003; 182: 412-420.
39. Santoro B, Bigini P, Levandis G, Nobile V, Biggiogera M, Botti F, Mennini T, Curti D. Evidence for chronic mitochondrial impairment in the cervical spinal cord of a murine model of motor neuron disease. Neurobiol Dis 2004; 17: 349-357.
40. Finocchietto PV, Franco MC, Holod S, Gonzalez AS, Converso DP, Antico Arciuch VG, Serra MP, Poderoso JJ, Carreras MC. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood) 2009; 234: 1020-1028.
41. Gonzalez Deniselle MC, Carreras MC, Garay L, Gargiulo-Monachelli G, Meyer M, Poderoso JJ, De Nicola AF. Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice. J Neurochem 2012; 122: 185-195.
42. Gargiulo Monachelli G, Meyer M, Rodríguez GE, Garay LI, Sica RE., De Nicola AF, González Deniselle MC. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol Scand, 2011; 123: 60-67.
43. Patacchioli FR, Monnazzi P, Scontrini A, Tremante E, Caridi I, Brunetti E, Buttarelli FR, Pontieri FE. Adrenal dysregulation in amyotrophic lateral sclerosis. J Endocrinol Invest 2003; 26: RC23-RC25.
44. Gargiulo Monachelli G, Sivori M, Meyer M, Sica R, De Nicola AF, Gonzalez Deniselle MC. Predictive value of circulating gonadal and adrenal steroids for respiratory function in patients with amyotrophic lateral sclerosis (ALS). Neurology, 2013; 80: P07.
45. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6: 169-175.
46. McQualter JL, Bernard CC. Multiple sclerosis: a battle between destruction and repair. J Neurochem 2007; 100: 295-306.
47. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247-269.
48. Matute C, Pérez-Cerdá F. Multiple sclerosis: novel perspectives on newly forming lesions. Trends Neurosci 2005; 28: 173-175.
49. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339: 285-291.
50. Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH, Steinman L, Baker GB, Power C. Impaired neurosteroid synthesis in multiple sclerosis. Brain 2011; 134: 2703-2721.
51. El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C. Steroid hormones in multiple sclerosis. J Neurol Sci 2005; 233: 49-54.
52. Ayers M, Hazelwood L.J, Catmull DV, Wang D, McKormack Q, Bernard CC, Orian JM. Early glial responses in murine models of multiple sclerosis. Neurochem Int 2004; 45: 409-419.
53. Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008; 15: 76-83.
54. Elloso MM, Phiel K, Henderson RA, Harris HA, Adelman SJ. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J Endocrinol 2005; 185: 243-244.
55. Yates MA, Li Y, Chlebeck P, Proctor T, Vandenbark AA, Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2010; 220: 136-139.
56. Yu HJ, Fei J, Chen XS, Cai QY, Liu HL, Liu GD, Yao ZX. Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein. Neurosci Lett 2010; 476: 42-45.
57. Spence RD, Voskuhl RR. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 2012; 33: 105-115.
58. Garay L, Gonzalez Deniselle MC, Lima A, Roig P, De Nicola AF. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J Steroid Biochem Mol Biol 2007; 107: 228-237.
59. Garay LI, González Deniselle MC, Brocca ME, Lima A, Roig P, De Nicola AF. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis. Neuroscience 2012; 226: 40-50.
60. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 2010; 30: 8285-8295.
61. Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011; 34: 269-281.
62. Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 2011; 121: 367-387.
63. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 2008; 28: 2320-2331.
64. Selmaj K, Raine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991; 30: 694-700.
65. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155: 128-133.
66. Muller E, Kerschbaum HH. Progesterone and its metabolites 5 dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol Lett 2006; 27: 675-678.
67. Su L, Sun Y, Ma F, Lu P, Huang H, Zhou JC. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol Lett 2009; 125: 151-155.
68. Chen G, Shi J, Jin W, Wang L, Xie W, Sun J, Hang C. Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion. Ann Clin Lab Sci 2008; 38: 65-74.
69. Cammer W. Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000; 864: 213-219.
70. Su Z, Yuan Y, Chen J, Zhu Y, Qiu Y, Zhu F, Huang A, He C. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-alpha. J Neurotrauma 2011; 28: 1089-1100.
71. MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002; 14: 477-492.
72. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004; 189: 404-412.
73. Gibson CL, Constantin D, Prior MJ, Bath PM, Murphy SP. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 2005; 193: 522-530.
74. Giatti S, D'Intino G, Maschi O, Pesaresi M, Garcia-Segura LM, Calza L, Caruso D, Melcangi RC. Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem Int 2010; 56: 118-127.
75. Garay L, Tüngler V, Deniselle MC, Lima A, Roig P, De Nicola AF. Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 2011; 192: 588-597.